
Ali Hosni
@dr_alihosni
Husband, Dad, Radiation oncologist, Clinician Scientist, and life long learner. Everybody deserves a smile
ID: 1367928913
20-04-2013 20:16:22
148 Tweet
399 Followers
391 Following

Aisling Barry showing us the ever expanding roles of SBRT in #hcc St Vincent's University Hospital (SVUH) Cancer Trials Cork CancerTrialsIreland 🌈 Laura Dawson


Princess Margaret no. 1 accrual for NRG Oncology trial in 2022. Looking forward for more collaboration with NRG Oncology Radiation Medicine Program


Proud of my colleague Jelena Lukovic, MD FRCPC MPH who recently awarded @CIHR grant to support NEEDS RCT (CROSS vs Definitive RT for esophgaeal cancer) with a total funding of $1,8 milllion. Looking forward for Canadian/European collaboration @CDNCancerTrial Radiation Medicine Program Laura Dawson

Exciting time Radiation Medicine Program Princess Margaret Cancer Centre! We formally integrated oligometastatic disease into our well known palliative radiotherapy program to provide comprehensive evaluation of patients for SBRT vs. palliative RT options. Read more 👇 mailchi.mp/eb4adfad0a18/r… #RadOnc #Cancer


Thrilled to announce enrollment of the 1st patient to #SELECT phase III RCT. Not only de-scalation, but also personalization of target volume selection. Not only HPV+ve, but also HPV-ve OPC John De Almeida CCTG James Bates Steven C. Jillian Tsai, MD, PhD Scott Bratman


Dr. Jelena Lukovic, MD FRCPC MPH, a radiation oncologist Princess Margaret Cancer Centre and #ECR award in cancer recipient, is part of the team leading an international clinical trial working to improve quality of life after treatment for esophageal cancer. cihr-irsc.gc.ca/e/53357.html?f…


Congratulations to #RMPatPM Princess Margaret Cancer Centre's Radiation Oncologist Dr. David Hodgson David Hodgson, who received the 2023 CARO-ACRO Gold Medal and Gordon Richards Lectureship! Dr. Hodgson will deliver his keynote presentation at the 2023 CARO-COMP ASM: caro-acro.ca/annual-scienti…


The inimitable John De Almeida Celebrating 10 years @ UHN and PMH Princess Margaret Cancer Centre, recently spotted in a Monday Masterclass with all fellows on deck.


Retirement celebration of a true great one, Richard Tsang! Wise, calm, and a wonderful mentor! Congratulations 🎉 Princess Margaret Cancer Centre Radiation Oncology


Congratulations to #RMPatPM Princess Margaret Cancer Centre's Dr. Kathy Han, whose study "Clinical validation of HPV ctDNA for early detection of residual disease following chemoradiation in #cervicalcancer" was selected for the 2023 ASTRO Annual Meeting Press Program! #ASTRO2023 #RadOnc


Thrilled to announce enrollment of first patient #MAESTRO Phase II trial (MR Adaptive RT for anal cancer with personalized dose selection:40-70Gy) Dr. Nina Niu Sanford Michael Yan, MD MPH William A Hall, MD David Kirsch, MD, PhD Laura Dawson Jelena Lukovic, MD FRCPC MPH Rebecca Wong Aruz mesci, John Kim Todd Aguilera MD PhD



The #ULTRAS trial collaborators are so excited to start accrual soon Todd Aguilera MD PhD Sunnybrook Health Sciences Centre Teo Stanescu Hendrick Tan Cihan Gani @Issa10079384 John Christodouleas Michael Yan, MD MPH Sweet Ping Ng RMP Clinical Research Program Radiation Medicine Program

#TeamUHN Drs. Erin Watson & Ali Hosni from UHN's Princess Margaret Cancer Centre led a research team to transform the way we classify and understand bone tissue death after #radiationtherapy for head and neck cancer. Read more 👇 bit.ly/3Sv2hEo


Exciting news: 1st pnt enrolled #ULTRAS. 1st multicenter MRgRT ph3 RCT for liver met. Single Fx SBRT: BED10 180 vs 100 to improve LC. Todd Aguilera MD PhD Sunnybrook Health Sciences Centre Teo Stanescu Hendrick Tan Issa Sweet Ping Ng Michael Yan, MD MPH Laura Dawson David Kirsch, MD, PhD MR-Linac Consortium John Christodouleas

🆕📢 Can patients with bone mets benefit from structured exercise regimen after radiation? The EXERT-BM trial, led by our junior faculty Michael Yan, MD MPH Radiation Medicine Program Princess Margaret Cancer Centre and sponsored by our own Palliative RT and Oligomet Program (PROP), is aimed to answer this crucial


🚨📢Pleased to announce the activation of CCTG BR38 (CURB2, Ph3 SBRT for Oligoprogressive NSCLC, NCT06686771). Trial can be accrued through NRG Oncology SWOG Cancer Research Network - info below. 🙏the support! ctg.queensu.ca/trials/lung/br… #NCTN Drew Moghanaki Alex Louie MD, PhD Jeff Bradley, MD OncoAlert


Yesterday we treated our first patient on the Ph3 #ULTRAS trial—on board within 1 week of activation! Single-fraction SABR to liver mets from ENTSCC, NSCLC, CervSCC, and gastric/pancreatic ADC. UTSW Simmons Cancer Center UTSW Radiation Oncology Ali Hosni Excited to team up w/ partners and move fast!